Baobin Xu
Overview
Explore the profile of Baobin Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xiao Z, Zhu X, Wang S, Shi Y, Zhang H, Xu B, et al.
Molecules
. 2024 Mar;
29(6).
PMID: 38543050
Stabilizing LiCoO (LCO) at 4.5 V rather than the common 4.2 V is important for the high specific capacity. In this study, we developed a simple and efficient way to...
2.
Hu R, Xu B, Ma J, Li L, Zhang L, Wang L, et al.
Mol Med
. 2023 Jan;
29(1):1.
PMID: 36604626
Background: Long intergenic non-coding RNA 00963 (LINC00963) is an oncogenic lncRNA in human cancers. However, little is known on how it impacts the pathogenesis of lung adenocarcinoma (LUAD). Methods: Biological...
3.
Zhang Z, Zong L, Xu B, Hu R, Ma M, Wei H, et al.
J BUON
. 2018 Mar;
23(1):150-156.
PMID: 29552775
Purpose: To observe the clinical efficacy of the application of enhanced recovery after surgery (ERAS) in the perioperative period of esophageal carcinoma patients. Methods: A total of 114 patients who...
4.
Zhang Z, Ma M, Hu R, Xu B, Zong L, Wei H, et al.
Clin Exp Pharmacol Physiol
. 2018 Feb;
45(7):720-728.
PMID: 29461644
Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers worldwide; however, clinical and pathological parameters have limited ability in discriminating between clinically significant and indolent ESCC. Since...
5.
Zhang Z, Li H, Yan C, Xu B, Hu R, Ma M, et al.
Oncol Lett
. 2017 Nov;
14(4):4812-4816.
PMID: 29085484
The purpose of our study was to evaluate the clinical efficacy of fast-track surgery (FTS) in the treatment of esophageal cancer patients combined with metabolic syndrome. Ninety-four esophageal cancer patients...